Filing Flows

Filing Flows › Companies › Nu Skin Enterprises › Cash flow

Nu Skin Enterprises cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$19.5M in Q3 2026 · −$26.3M over twelve months

Operating cash flow−$8.1M
Capital spending−$11.3M
Free cash flow−$19.5M
Cash conversion cycle150 days

Analysis

In Q3 2026, Nu Skin Enterprises generated −$8.1M of operating cash flow and spent $11.3M on capital projects, leaving free cash flow of −$19.5M. That is $37.0M less than in Q3 2025 ($17.6M).

Over the twelve months to Sep 30, 2026, operating cash flow was $15.2M; the largest uses were capital spending ($41.5M), net borrowing (+) / repaid (−) ($27.0M), buybacks ($15.0M); besides operations, cash came from other investing ($6.6M); the cash balance fell by $86.9M.

Operating cash flow was −$8.1M against net income of −$742K. The largest differences: accrued liabilities −$21.2M, depreciation & amortization +$12.5M, payables −$11.7M.

Its cash conversion cycle was 150 days (receivables 15 + inventory 162 − payables 27).

Free cash flow

Nu Skin Enterprises: free cash flow by quarterNu Skin Enterprises: free cash flow by quarter$13.2MQ4 2024−$13.2MQ1 2025$35.8MQ2 2025$17.6MQ3 2025$5.9MQ4 2025−$17.6MQ1 2026$5.0MQ2 2026−$19.5MQ3 2026
Operating cash flow less capital spending.
Nu Skin Enterprises: operating cash flow against capital spendingNu Skin Enterprises: operating cash flow against capital spendingOperating cash flowCapital spending$25.8M$12.6MQ4 2024$389K$13.6MQ1 2025$35.8M$18KQ2 2025$27.5M$9.9MQ3 2025$16.6M$10.8MQ4 2025−$3.9M$13.7MQ1 2026$10.6M$5.6MQ2 2026−$8.1M$11.3MQ3 2026
Latest (Q3 2026): Operating cash flow −$8.1M, Capital spending $11.3M.

Capital allocation, year by year

Nu Skin Enterprises: where the cash came from (up) and went (down), by fiscal yearNu Skin Enterprises: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingAsset salesCapital spendingAcquisitionsBuybacksDividendsFY2021: Operating cash flow $142MFY2021: Net borrowing $38.1MFY2021: Capital spending −$68.6MFY2021: Acquisitions −$19.0MFY2021: Buybacks −$80.4MFY2021: Dividends −$76.3M$180MFY2021FY2022: Operating cash flow $108MFY2022: Net borrowing $25.6MFY2022: Capital spending −$59.1MFY2022: Buybacks −$70.0MFY2022: Dividends −$77.0M$134MFY2022FY2023: Operating cash flow $119MFY2023: Net borrowing $96.8MFY2023: Capital spending −$58.5MFY2023: Acquisitions −$77.3MFY2023: Buybacks −$13.0MFY2023: Dividends −$77.6M$215MFY2023FY2024: Operating cash flow $112MFY2024: Net borrowing −$113MFY2024: Capital spending −$41.6MFY2024: Dividends −$11.9M$112MFY2024FY2025: Operating cash flow $80.3MFY2025: Net borrowing −$172MFY2025: Asset sales $194MFY2025: Capital spending −$34.3MFY2025: Buybacks −$20.0MFY2025: Dividends −$11.8M$274MFY2025
Over these 5 years operating cash flow totalled $560M; the largest uses were net borrowing ($285M) and capital spending ($262M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$167M
Debt$204M
Net debt$37.1M
Due within a year$20.0M
Cash runway2.1 years

Nu Skin Enterprises is burning cash: its operations consume cash, a free cash flow of −$77.9M a year at the current rate against $167M of cash and investments: a runway of about 2.1 years; $20.0M of debt also comes due within a year, which the cash covers before any new financing.

Nu Skin Enterprises: debt maturities by year (FY2025)Nu Skin Enterprises: debt maturities by year (FY2025)$20.0MYear 1$205MYear 2
Principal due in each year as disclosed in the annual report, against $167M of cash and investments now.

Where the cash came from and went

Nu Skin Enterprises: sources (+) and uses (−) of cash, Q3 2026Nu Skin Enterprises: sources (+) and uses (−) of cash, Q3 2026Cash drawn (+) / kept (−)$24.7MCapital spending−$11.3MNet borrowing (+) / repaid (−)−$10.5MOperating cash flow−$8.1MOther investing$6.2MDividends−$2.9MExchange rates$2.0M
Nu Skin Enterprises: sources (+) and uses (−) of cash, TTM to Q3 2026Nu Skin Enterprises: sources (+) and uses (−) of cash, TTM to Q3 2026Cash drawn (+) / kept (−)$86.9MCapital spending−$41.5MNet borrowing (+) / repaid (−)−$27.0MOperating cash flow$15.2MBuybacks−$15.0MOther financing−$12.1MDividends−$11.6MOther investing$6.6MExchange rates−$1.5M

From profit to cash

Nu Skin Enterprises: net income to operating cash flow, Q3 2026Nu Skin Enterprises: net income to operating cash flow, Q3 2026Net income−$742KDepreciation & amortization$12.5MStock-based pay$2.7MGains on disposals$337KReceivables−$2.5MInventory−$1.2MPayables−$11.7MAccrued liabilities−$21.2MPrepaid and other assets$6.1MOther liabilities−$2.1MOperating cash flow−$8.1M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 20261516227150
Q2 20261316530149
Q1 20261215123140
Q4 20251115223139
Q3 20251415425143
Q2 20251414024130
Q1 20251314526132
Q4 20241212119115

Every quarter

QuarterOperating cash flowCapital spendingBuybacksDividendsNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q3 2026−$8.1M−$11.3M—−$2.9M−$10.5M$24.7M−$19.5M
Q2 2026$10.6M−$5.6M—−$2.9M−$10.5M$9.0M$5.0M
Q1 2026−$3.9M−$13.7M−$5.0M−$2.9M−$489K$40.0M−$17.6M
Q4 2025$16.6M−$10.8M−$10.0M−$2.9M−$5.5M$13.2M$5.9M
Q3 2025$27.5M−$9.9M−$5.0M−$3.0M−$20.6M$12.4M$17.6M
Q2 2025$35.8M−$18K—−$3.0M$9.5M−$60.4M$35.8M
Q1 2025$389K−$13.6M−$5.0M−$3.0M−$156M−$16.9M−$13.2M
Q4 2024$25.8M−$12.6M—−$3.0M−$40.6M$40.9M$13.2M

Nu Skin Enterprises: income statement and cash flow

Nu Skin Enterprises, Q3 2026: revenue $311M (-15% year over year), operating margin 1.6%. The chart follows the revenue to costs, profit and cash.

Nu Skin Enterprises: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.